Drug Approval | January 14, 2022
Glenmark receives U.S. FDA approval for Ryaltris
The recommended daily dose for Ryaltris is 2 sprays in each nostril twice daily
The recommended daily dose for Ryaltris is 2 sprays in each nostril twice daily
Victor Chang Cardiac Research Institute (VCCRI) researcher recognized for his influential work on cardiovascular disease
The R&D centre will endeavour to bring scientifically advanced biological, biotechnology products and novel drug delivery systems
Hitz shall assume new role from January 17th, 2022
Fexofinadine is the most widely used, second-generation antihistamine drug for the treatment of allergy symptoms and hay fever
The company is marketing the kit under the brand name CoviFind and it can detect the infection in 15 minutes
The NDA for Desidustat is based on positive data from the DREAM-ND and DREAM-D Phase 3 trials in patients with Chronic Kidney Disease (CKD) Not on Dialysis and Dialysis
If approved or authorized, Paxlovid would be the first oral antiviral of its kind, to combat SARS-CoV-2
Data demonstrates Ronapreve reduced risk of hospitalisation in certain patients and reduced risk of symptomatic Covid-19 infections in people exposed to the virus
A final decision regarding the approval of Ronapreve is expected from the European Commission shortly
Subscribe To Our Newsletter & Stay Updated
